Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC10914 in gBRCAm Metastatic Breast Cancer
NCT04556292Phase 2Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SC10914 in breast cancer, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Status: unknown.
02
Drugs
SC10914
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04556292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556292.